U.S. flag

An official website of the United States government

NM_000094.4(COL7A1):c.6127G>T (p.Gly2043Trp) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 22, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000479380.2

Allele description [Variation Report for NM_000094.4(COL7A1):c.6127G>T (p.Gly2043Trp)]

NM_000094.4(COL7A1):c.6127G>T (p.Gly2043Trp)

Gene:
COL7A1:collagen type VII alpha 1 chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p21.31
Genomic location:
Preferred name:
NM_000094.4(COL7A1):c.6127G>T (p.Gly2043Trp)
HGVS:
  • NC_000003.12:g.48575392C>A
  • NG_007065.1:g.24861G>T
  • NM_000094.4:c.6127G>TMANE SELECT
  • NP_000085.1:p.Gly2043Trp
  • NP_000085.1:p.Gly2043Trp
  • LRG_286t1:c.6127G>T
  • LRG_286:g.24861G>T
  • LRG_286p1:p.Gly2043Trp
  • NC_000003.11:g.48612825C>A
  • NM_000094.3:c.6127G>T
Protein change:
G2043W
Links:
dbSNP: rs121912836
NCBI 1000 Genomes Browser:
rs121912836
Molecular consequence:
  • NM_000094.4:c.6127G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000567551GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Nov 22, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000567551.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.G2043W substitution in the COL7A1 gene has been reported previously as a pathogenic variantand is the same position as the most common recurrent autosomal dominant COL7A1 variant (G2043R)in DDEB patients (Varki et al 2006). The p.G2043W variant was not observed in approximately 6500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. The p.G2043W variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this substitution is probably damaging to the protein structure/function as it occurs at the first Glycine position of the canonical Gly-X-Y repeat in the collagenous domain of the COLVII protein. Glycine substitution variants in this region of the collagen VII protein will destabilize the collagen triplehelix resulting in anchoring fibrils that are unstable and result in poor anchoring off the basementmembrane to the underlying dermis. Missense variants at the same residue (G2043R, G2043E) andnearby residues (G2031S, G2037R) have been reported in the Human Gene Mutation Database inassociation with DEB (Stenson et al., 2009), supporting the functional importance of this region of theprotein. We interpret G2043W in COL7A1 as a pathogenic variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022